Advertisement

Topics

TapImmune Amends Phase II Clinical Trial To Focus On Larger Population Of Women With Platinum-Sensitive Ovarian Cancer With Greatest Unmet Need For New Treatments

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: TapImmune Amends Phase II Clinical Trial To Focus On Larger Population Of Women With Platinum-Sensitive Ovarian Cancer With Greatest Unmet Need For New Treatments

NEXT ARTICLE

More From BioPortfolio on "TapImmune Amends Phase II Clinical Trial To Focus On Larger Population Of Women With Platinum-Sensitive Ovarian Cancer With Greatest Unmet Need For New Treatments"

Quick Search
Advertisement